Hematopoietic stem cell mobilization in relapsed or refractory lymphomas: A multi-center experience with BEGEV± rituximab. // Transfusion and Apheresis Science. – URL: https://www.sciencedirect.com/science/article/pii/S1473050226001965?dgcid=rss_sd_all
Hematopoietic stem cell mobilization in relapsed or refractory lymphomas: A multi-center experience with BEGEV± rituximab. Transfusion and Apheresis Science. https://www.sciencedirect.com/science/article/pii/S1473050226001965?dgcid=rss_sd_all
“Hematopoietic stem cell mobilization in relapsed or refractory lymphomas: A multi-center experience with BEGEV± rituximab.” Transfusion and Apheresis Science.
@article{article69897,
title = {Hematopoietic stem cell mobilization in relapsed or refractory lymphomas: A multi-center experience with BEGEV± rituximab},
journal = {Transfusion and Apheresis Science},
url = {https://www.sciencedirect.com/science/article/pii/S1473050226001965?dgcid=rss_sd_all}
}